A 61 years old male had minimally symptomatic SARS-CoV-2 infection while
taking everolimus. He remained RT-PCR positive for viral RNA for 52
days. Pegylated interferon for 4 weeks led to viral RNA clearance. The
observations support consideration and further evaluation of combination
therapy with everolimus plus interferon for COVID-19.